| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 74,672 | 73,000 | 61,229 | 41,334 | | Cost of Revenue | 45,637 | 50,417 | 41,252 | 31,764 | | | Gross Profit | 29,035 | 22,583 | 19,977 | 9,570 | | | Operating Expenses | | Research Development | 5,416 | 4,528 | 4,769 | 5,305 | | Selling General and Administrative | 12,712 | 10,885 | 10,374 | 9,400 | | Non Recurring | 117 | 334 | 362 | 168 | | Others | 460 | 445 | 431 | 433 | | | | Total Operating Expenses | 18,705 | 16,192 | 15,936 | 15,306 | | | | Operating Income or Loss | 10,330 | 6,391 | 4,041 | (5,736) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (681) | (1,733) | 436 | 274 | | Earnings Before Interest And Taxes | 9,649 | 4,658 | 4,477 | (5,462) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 9,649 | 4,658 | 4,477 | (5,462) | | Income Tax Expense | 5,309 | 2,866 | 3,169 | 2,310 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,340 | 1,792 | 1,308 | (7,772) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,340 | 1,792 | 1,308 | (7,772) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,340 | $1,792 | $1,308 | ($7,772) |
|
0.16% Nasdaq 
Income Statement
